IN2013MU03422A - - Google Patents

Info

Publication number
IN2013MU03422A
IN2013MU03422A IN3422MU2013A IN2013MU03422A IN 2013MU03422 A IN2013MU03422 A IN 2013MU03422A IN 3422MU2013 A IN3422MU2013 A IN 3422MU2013A IN 2013MU03422 A IN2013MU03422 A IN 2013MU03422A
Authority
IN
India
Prior art keywords
pharmaceutically acceptable
acceptable derivative
sulbactam
stereoisomer
compound
Prior art date
Application number
Other languages
English (en)
Inventor
Sachin Bhagwat
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3422MU2013 priority Critical patent/IN2013MU03422A/en
Priority to EP14806075.9A priority patent/EP3062793A1/en
Priority to RU2016115375A priority patent/RU2016115375A/ru
Priority to MX2016005539A priority patent/MX2016005539A/es
Priority to CN201480059506.8A priority patent/CN106163519A/zh
Priority to AU2014343327A priority patent/AU2014343327A1/en
Priority to PCT/IB2014/065523 priority patent/WO2015063653A1/en
Priority to CA2928368A priority patent/CA2928368A1/en
Priority to US15/030,607 priority patent/US20160287571A1/en
Priority to JP2016526935A priority patent/JP2016535038A/ja
Publication of IN2013MU03422A publication Critical patent/IN2013MU03422A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN3422MU2013 2013-10-30 2014-10-22 IN2013MU03422A (sl)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IN3422MU2013 IN2013MU03422A (sl) 2013-10-30 2014-10-22
EP14806075.9A EP3062793A1 (en) 2013-10-30 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
RU2016115375A RU2016115375A (ru) 2013-10-30 2014-10-22 Фармацевтические композиции, содержащие антибактериальные агенты
MX2016005539A MX2016005539A (es) 2013-10-30 2014-10-22 Composiciones farmaceuticas que comprenden agentes antibacterianos.
CN201480059506.8A CN106163519A (zh) 2013-10-30 2014-10-22 包含抗菌剂的药物组合物
AU2014343327A AU2014343327A1 (en) 2013-10-30 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
PCT/IB2014/065523 WO2015063653A1 (en) 2013-10-30 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
CA2928368A CA2928368A1 (en) 2013-10-30 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
US15/030,607 US20160287571A1 (en) 2013-10-30 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
JP2016526935A JP2016535038A (ja) 2013-10-30 2014-10-22 抗菌剤を含む医薬品組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3422MU2013 IN2013MU03422A (sl) 2013-10-30 2014-10-22

Publications (1)

Publication Number Publication Date
IN2013MU03422A true IN2013MU03422A (sl) 2015-07-17

Family

ID=52003013

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3422MU2013 IN2013MU03422A (sl) 2013-10-30 2014-10-22

Country Status (10)

Country Link
US (1) US20160287571A1 (sl)
EP (1) EP3062793A1 (sl)
JP (1) JP2016535038A (sl)
CN (1) CN106163519A (sl)
AU (1) AU2014343327A1 (sl)
CA (1) CA2928368A1 (sl)
IN (1) IN2013MU03422A (sl)
MX (1) MX2016005539A (sl)
RU (1) RU2016115375A (sl)
WO (1) WO2015063653A1 (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016151543A1 (en) * 2015-03-25 2016-09-29 Wockhardt Limited Pharmaceutical compositions comprising antibacterial agents
EP3719020B1 (en) 2017-12-01 2022-09-21 Qilu Pharmaceutical Co., Ltd. Crystal form of beta-lactamase inhibitor and preparation method therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2748165T3 (pl) * 2011-08-27 2017-05-31 Wockhardt Limited Pochodne 1,6-diazabicyklo[3,2,1]oktan-7-onu i ich zastosowanie w leczeniu zakażeń bakteryjnych

Also Published As

Publication number Publication date
RU2016115375A3 (sl) 2018-07-18
CA2928368A1 (en) 2015-05-07
CN106163519A (zh) 2016-11-23
EP3062793A1 (en) 2016-09-07
AU2014343327A1 (en) 2016-05-12
MX2016005539A (es) 2016-10-03
WO2015063653A1 (en) 2015-05-07
RU2016115375A (ru) 2017-12-01
US20160287571A1 (en) 2016-10-06
JP2016535038A (ja) 2016-11-10

Similar Documents

Publication Publication Date Title
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
MX2018002986A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y sus usos.
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
IN2014MN02598A (sl)
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MY181641A (en) Amino pyran ring derivative and composition and use thereof
MX2017016619A (es) Derivados de pirimidina como inhibidores de tirosina cinasa de bruton (btk) y usos de los mismos.
MY162886A (en) Novel tetrahydropyridopyrimidine compound or salt thereof
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MX2016001138A (es) Compuestos de benzoxaborol triciclico, metodo de preparacion y uso del mismo.
EP3003360A4 (en) High potency pancreatin pharmaceutical compositions
AU2015292632B2 (en) Aldosterone synthase inhibitors
IN2013MU01985A (sl)
IN2013MU03422A (sl)
IN2013MU03704A (sl)
IN2013MU03308A (sl)
IN2013MU03309A (sl)
IN2014MU00859A (sl)
IN2013MU03421A (sl)
IN2013MU03565A (sl)
IN2013CH04314A (sl)
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.